Conference Call: Thermo Fisher Scientific Raises FY2026 Adj EPS Guidance from $24.22-$24.80 to $24.64-$25.12 vs $24.64 Est; Raises FY2026 Sales Guidance from $46.300B-$47.200B to $47.300B-$48.100B vs $47.109B Est

Thermo Fisher Scientific (NYSE:TMO) raises FY2026 Adj EPS guidance from $24.22-$24.80 to $24.64-$25.12 vs $24.64 analyst estimate. Raises FY2026 sales outlook from $46.300 billion-$47.200 billion to $47.300 billion-$48.100 billion vs $47.109 billion estimate.